News

News

2022.01.11Hanmi Pharm Set to Produce DNA-based COVID-19 Vaccine Developed by Zydus Cadila 2022.01.10Hanmi Pharm Simultaneously Releases Single-Active-Ingredient and Combination Drugs of V... 2022.01.05Hanmi Pharm Makes Strategic Investment of KRW 24 B in Spectrum 2022.01.03Hanmi Pharm Signs Agreement to Transfer the Rights to New Drug for Eye Diseases in Ch... 2022.01.03Hanmi Pharm Promises to Dedicate Itself to Global New Drug Research and Set an Exampl... 2021.12.30Hanmi Pharm Wins at Security Awards Korea for Excellence in Information Security 2021.12.28Hanmi Pharm Sponsors the Korean Theater People Festival Hosted by the Korea Theater Ass... 2021.12.24Free Zia, YouTuber with More Than 640,000 Subscribers, Endorses PRO-CALM 2021.12.23Hanmi Pharmaceutical Group Donates KRW 55.2 B over a Decade for “Sustainable Sharing o... 2021.12.22Kim In-san, Principal Researcher at KIST, awarded the 1st Lim Sung-ki Researcher Award... 2021.12.22Hanmi Pharm’s First-in-Class Drug for Targeted Therapy Selected for National New Drug... 2021.12.20Hanmi Pharmaceutical Group Makes Donation to the Korean National Tuberculosis Association 2021.12.17Hanmi Pharm Chairwoman Song Young-sook Selects Three Proud Members of Hanmi 2021.12.17Hanmi Pharm Honored with the Presidential Award at the Korea Brand Awards 2021.12.17Hanmi Pharm’s New Drug for Liver Disease Receives Orphan Drug Designation in Europe 2021.12.14Hanmi Pharm Forecasts Operating Profit of KRW 114 Billion, a Sign of Overcoming the C... 2021.12.14Hanmi Pharm Confirms Complete Response in Patients with Refractory Acute Leukemia 2021.12.13Hanmi’s Tenten and Nunaen Selected as Good Brands by 1,000 Pharmacists 2021.12.10Hanmi Pharm Is Being Proactive About Climate Change 2021.12.08Hanmi Pharm’s Study on New Drug for Diabetes Chosen as Late Breaker by AHA 2021.12.08Hanmi Pharm Presents Results of Follow-up Study to Phase 3 Clinical Trial on Efpeglenat... 2021.12.07Dr. Kim Dae-hyeon Wins Grand Prize at Hanmi Literary Awards, the Most Prestigious Lit... 2021.12.06Hanmi Pharm Applies for FDA Marketing Approval for Poziotinib, a First-in-Class Drug f... 2021.12.06“Avoid Small Marketing Agencies for Successful Marketing in China” 2021.12.06Hanmi Pharm Set to “Announce a Joint Development Plan with a Global LNP Company T... 2021.12.05Dr. Jang Cheol-ho and Seoul Red Cross Hospital Honored with Hanmi True Medical Persona... 2021.12.02Hanmi Pharm Begins Phase 3 Clinical Trial on Cardiovascular Disease Medication, HCP180... 2021.12.01Hanmi Pharm Launches Low-Dose Rosuzet Containing Ezetimibe and Rosuvastatin 2021.11.28Hanmi Pharm Reinvests 20% of Sales in R&D to Bring Forth First-in-Class Drug Product... 2021.11.26Hanmi Pharm Successfully Conducting Clinical Trials Along with the Release of Poziotinib... 2021.11.25Hanmi Omega 3 Max Lowering the Chance of Memory Decline and Improving Blood Flow 2021.11.25Hanmi Pharm Releases New and Improved Zeten-C Reinforced with Zinc and Vitamin C 2021.11.19JVM Receives Ministerial Prize as Excellent Company in Responding to International Enviro... 2021.11.18Ofmom Korea Signs Sponsorship Agreement for Atopy Patients 2021.11.18Hanmi Pharm Presents Phase 2 Clinical Study on CCR4-Targeting Anticancer Agent 2021.11.18COREE partners with Infini Fluidics to develop new mRNA vaccine-making method 2021.11.15Hanmi Pharm Announces Results of Phase 4 Clinical Study on Amozaltan Family 2021.11.11Hanmi Pharm Acquires ISO 45001 Certification for All Its Business Establishments 2021.11.11Hanmi Pharm Gears up for Global Commercialization of First-in-Class Drug for Three Can... 2021.11.08InnoRNA Joins Hanmi Science Consortium to “Eliminate Vaccine Inequality” 2021.11.08Hanmi Pharm’s First-in-Class Drug for Rare Disease Selected for National New Drug De... 2021.11.08Hanmi Pharm Records 13% Higher Sales in Q3 with Growth of Beijing Hanmi 2021.11.05Hanmi Pharmaceutical Ranks No. 1 in Sustainability Management in Pharmaceutical Industry ... 2021.11.04Hanmi Pharm Licenses New Drug for Acute Myeloid Leukemia for up to KRW 482.9 B 2021.11.04Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi... 2021.11.01Hanmi Pharm Launches Its First Biologic, Rolontis, in Korea 2021.10.28Hanmi Science Joins Forces with AstraZeneca Team at Oxford to Prepare Against Future P... 2021.10.28Hanmi Science Signs Agreement with University of Oxford for Pandemic Science Alliance ... 2021.10.27Hanmi Pharm Obtains Approval for Esomezol Plus, Combination Drug Consisting of PPI an... 2021.10.25Lim Chong-yoon, CEO of Hanmi Science, Appointed as Director of Cancer ROP 2021.10.21CancerRop Concludes Immune Cell Profiling Research Agreement to Build Big Data for Vac... 2021.10.19The Lancet Publishes Paper on New Biologic Developed by Hanmi 2021.10.17Hanmi Pharm Expecting Double-Digit Growth for “Children’s Medications” in China Ami... 2021.10.15Hanmi Pharm Joins UNGC to Contribute to Sustainable Development 2021.10.14Hanmi Pharmaceutical’s Clinical Trial on New Drug for NASH Recommended to Continue... 2021.10.12Joint Marketing Campaign for Probiotic Supplement, SynterAct, and Postpartum Care Cente... 2021.10.08Clinical Trial Results on Hanmi Pharm’s Poziotinib Published in SCI Journal 2021.09.29Beijing Hanmi Pharmaceutical Unveils Clinical Results on Bispecific Antibody in China 2021.09.27Hanmi Pharmaceutical Receives Marketing Approval for Low-Dose Rosuzet 2021.09.18Hanmi Pharmaceutical Unveils Clinical Trial Results on Oral Anticancer Agent at ESMO ... 2021.09.13Hanmi Pharm Presents Findings on New Drug for Short Bowel Syndrome at ESPEN Cong... 2021.09.07Hanmi Developing New Biologics for Orphan Drug Market 2021.09.06Hanmi Pharm’s Rosuzet Expected to Shatter the KRW 100 B Annual Sales Mark 2021.09.01Hanmi Pharm Emerges as No. 1 Orphan Drug Manufacturer in Korea 2021.08.31Hanmi Pharmaceutical achieved the digitalization of logistics channels through Online Farm an... 2021.08.23Hanmi Pharmaceutical’s Maxibufen Syrup, ranking first in pediatric prescriptions for the eigh... 2021.08.20Hanmi Pharmaceutical’s sales in the first half of this year were ₩ 549.6 billion…3.4%↑Y... 2021.08.18Hanmi Pharmaceutical to introduce low-dose rosuvastatin as a single drug product for the first ... 2021.08.17Lim Sung-ki, the founder, chairman and CEO of Hanmi Pharmaceutical Group, dreams of ma... 2021.08.14Hanmi Pharmaceutical was approved for its drug candidate for the treatment of NASH, to con... 2021.08.12Financial performance of Beijing Hanmi Pharm. Co., Ltd. is expected to recover to pre-COV... 2021.08.10Hanmi Pharmaceutical is taking steps to develop an mRNA coronavirus vaccine… “If it is dev... 2021.08.05Mamiai from Bejing Hanmi Pharmaceutical Wins over Countless Mothers in China 2021.07.31Hanmi Pharmaceutical Makes Turnaround in Second Quarter with 120% Growth in Sales 2021.07.29Hanmi Pharmaceutical Makes Turnaround in Second Quarter with 120% Growth in Sales 2021.07.29Hanmi Pharmaceutical Tops Domestic Prescription Market in First Half 2021.07.23Hanmi Pharmaceutical Group and Lego Chem Bio Partner up to Jointly Develop ADC for C... 2021.07.21R&D Turned into Growth Engine of Hanmi Pharmaceutical by Co-CEOs Woo Jong-soo and K... 2021.07.15Hanmi Pharmaceutical Develops HIP2105, a Combination Drug for Gastroesophageal Reflux D... 2021.07.12MSD and Hanmi Pharmaceutical Kick off the First Global Clinical Trial for a New Drug ... 2021.07.06Hanmi Pharmaceutical Vying for the Position of “Vaccine Hub” 2021.07.01KNIH Verifies Hanmi Fine Chemical’s mRNA Technology 2021.07.01Korea National Institute of Health (KNIH) conducts field inspection of companies with mRN... 2021.06.16President Lim Chong-yoon of Hanmi Science, “It’s possible to swiftly supply mRNA vacci... 2021.06.07New Cancer Drug from Hanmi Pharmaceutical Garners Attention at ASCO 2021 2021.05.31Hanmi Science and GeneOne Life Science Build Infrastructure for Mass Production of mRNA... 2021.05.18Hanmi Pharmaceutical Set to Manufacture COVID-19 Vaccine Developed by Genexine 2021.05.12Hanmi Pharmaceutical’s New Biologic Receives Another Orphan Drug Designation from US... 2021.04.27Hanmi Pharmaceutical Records 101.7% Growth in Net Profit in Q1 2021.04.20Hanmi Pharmaceutical Set to Export a Hypertension and Hyperlipidemia Drug to Russia via S... 2021.04.12Hanmi Sees the Potential of Digital Therapeutics Developer, Herings 2021.04.07Hanmi Pharmaceutical’s Therapeutic Agent for Short Bowel Syndrome Gets Fast Track De... 2021.04.02Peking Union Medical College Hospital held an opening meeting for exploratory research project... 2021.03.31Hanmi Pharmaceutical Targeting the KRW 560 B Chinese Market with Injectable Antibiotics 2021.03.24Hanmi Pharmaceutical, with No. 1 ETC Drug Sales in Korea for 3 Years, Invests 21% of I... 2021.03.19Rolontis, the 33rd New Drug Developed in Korea, Obtains Approval 2021.03.16Hanmi Pharm: “Pozitionib Granted Fast-track Designation by the U.S. FDA” 2021.02.22Hanmi’s Innovative New NASH Drug Wins the Technology Export Award at the Korea New... 2021.02.08Hanmi Pharm, Approved for Phase II Clinical Trials for an Oral Immunotherapy Drug by the... 2021.02.02Hanmi Pharmaceutical Releases Amozaltan XQ for Hypertension and Dyslipidemia Treatment 2021.01.25Hanmi Pharmaceutical’s Milestones in the Pharmaceutical Industry 2021.01.19Hanmi Set to Release Quick COVID-19 Test Kit 2021.01.13Hanmi’s Special Task Force Set to Develop Digital Therapy for COVID-19 2021.01.07COVID-19 Vaccines Differing in Mechanism and Characteristics 2020.12.23K-Bio Speeds up Development of Green Vaccine for COVID-19 2020.12.031 Billion Doses a Year… It Will Become an Outpost for the Consigned Production of a Coron... 2020.11.30Hanmi Pharm. Wins the First K-ICT Information Protection Excellence Award in the Phar... 2020.11.10Hanmi, get approval for four-drug combination, “Amosartan XQ” 2020.10.29JVM, an affiliate of Hanmi Pharm, recorded sales of KRW 84.9 billion in Q3, growing by 7... 2020.10.17LIFE OFMOM APP from OFMOM Won the ‘2020 Good Design Award’ 2020.10.16Hanmi Pharm has been Selected as the No. 1 Company for ‘Corporate Sustainability Managem... 2020.09.28Hanmi Science “Heavy responsibility…Devote to trust management based on morality” 2020.09.25Hanmi Pharmaceutical’s NASH- proved its potential as an innovative drug for obesity 2020.09.22Hanmi Pharmaceutical, “Poziotinib Shows a Significant Result for Cohort 2” 2020.09.17Syntekabio-Hanmi Science, Develop ‘Inhalation-type Treatment for COVID-19’ 2020.08.05Hanmi Pharm’s LAPSGLP/GCG Technology Export Has Created "Three birds with one s... 2020.08.04Hanmi Pharm’s New Drug Substance Returned by Janssen Has Exported 1 Trillion Won of T... 2020.07.30Hanmi Science and Theragen Sign MOU for Joint Development of Genetic Analysis Method 2020.07.29Hanmi Science, Laying the Cornerstone for the Six Visions through Medical Science Center 2020.07.13Hanmi Science- Bioapp “Green bio-based COVID-19 vaccine on full-scale development” 2020.06.29Celltrion•Samsung Biologics•Hanmi Science•Samsung Pharmaceutical speed up for the bio ... 2020.06.18CEO Chong-Yoon Lim will lead ‘Post COVID-19’ in Hanmi Pharmaceutical Group 2020.06.17Hanmi Science Launch innovative ‘Green Bio’ drug development platform and manufacturing s... 2020.06.17Hanmi Science Oral Vaccine Platform to give a next generation Orascovery science 2020.06.15Hanmi Science Set Up A "Smart Healthcare" Complex in Pohang, Gyeongsangbuk-do 2020.06.15Hanmi Science Presents 6 Great Visions for Post COVID-19 2020.04.21Chaer Dairy Received Two Subsidies from Government 2019.12.18Chongyoon Lim's Representative Departed to China and Italy to Unveil the "Second Act" of H... 2019.12.06"Medi Jointown to Prosperity, Care China to Health", A Successful Cooperation between Jo... 2019.11.25Hanmi Science and Pohang University of Science and Technology (North Gyeongsang, South Ko... 2019.11.19COREE Group, an Affiliate of Hanmi Science, "Promotes FDA Approval of One-to-One C... 2019.11.15COREE Group and Peking Union Medical Foundation Establish Metabolic Diseases Preventio... 2019.11.04[Asian Invitation Seat] "South Korean biological medicine is mixed with both joy and sorrow ... 2019.03.01Chongyoon-Lim, the CEO of Hanmi Science Creating "Dong-Ui-Bo-Gam" of Bio-Bank. 2019.02.13Chongyoon Lim, new Chairman of Korean Biological Association, said he would strive to buil... 2019.02.11SandBox genetic analysis has been expanded to 25 types, and the market scale has been expanded co... 2019.02.11Chairman Chongyoon-Lim: Time to Bring the Power of South Korea Biology into Play 2019.02.11In order to ensure a fair and just enterprise, listed subsidiaries of Hanmi Pharm. set up Board... 2018.12.12In Rome, the first International Symposium on the care of mother and child 2018.11.02The first Ofmom Centre for postpartum care of mothers and newborns is opening in Rome, Ita... 2018.06.13Hanmi Science Set Up a Maternal and Infant Biobank in Rome 2018.04.12Public Health: The “Mothers’ Road” Joins “Belt and Road” 2018.04.12Chongyoon-Lim, the representative of Hanmi Science, concluded and entered into the Agreement... 2018.04.12Create the milk powder for the world with the mothers' sincerity and love 2018.04.12Hanmi Pharm. Co., Ltd.--Sungki-Lim&Chongyoon-Lim Signed and Concluded the Public Me... 2018.04.12MAMIAIWas Selected in the 2016 Most Internet Influential Drug Brand List 2018.04.12MAMIAI Won the Top 10 Brand Construction Awards of the 10th "Healthy China 2030 Brand P... 2018.04.12MAMIAI Took the First Place in Gastrointestinal Drug Brand List of "Tmall Pharmacy" 2018.04.12Analysis on Market Share of Domestic Pediatric Gastrointestinal Drugs in the First Half of... 2017.12.03Public Health: The “Mothers’ Road” Joins “Belt and Road” 2017.10.28"YUN·YU" -- CENTRE OFMOM invites you to talk with your baby for the first time 2017.10.23Create the milk powder for the world with the mothers' sincerity and love Ofmom Company i... 2017.10.05Chongyoon-Lim, the representative of Hanmi Science, concluded and entered into the Agreement... 2017.08.01Ofmom leads the new
cultural trend of feeding by releasing
infant formula liquid mil...
2016.11.23Ofmom Won Laurel of 2016 Sina Baby Annual “Trusted Intestinal Health Brand of Chinese M... 2016.11.20Ofmom Antenatal Training Concert Comes again Warmly to Play Pregnant Love Melody 2016.07.01Ofmom “Growth Caring Tour” Walks into Luoyang Children Welfare Home